Literature DB >> 26024116

Fluorescence lifetime imaging in retinal artery occlusion.

Chantal Dysli, Sebastian Wolf, Martin S Zinkernagel.   

Abstract

PURPOSE: Fluorescence lifetime imaging ophthalmoscopy is a technique to measure decay times of endogenous retinal fluorophores. The purpose of this study was to investigate fluorescence lifetimes in eyes with central and branch retinal artery occlusion.
METHODS: Twenty-four patients with central or branch retinal artery occlusion were included in this study. The contralateral unaffected fellow eye was used as control. Measurements were performed using a fluorescence lifetime imaging ophthalmoscope based on a HRA Spectralis system. Fluorescence excitation wavelength was 473 nm, and mean lifetimes were measured in a short (498-560 nm) and in a long (560-720 nm) spectral channel. Fluorescence lifetimes in the area of retinal artery occlusion were measured and compared to corresponding areas in contralateral unaffected eyes. Additionally, findings were correlated to optical coherence tomography measurements.
RESULTS: Retinal lifetime images of 24 patients with retinal artery occlusion were analyzed. Mean retinal fluorescence lifetimes were prolonged by 50% in the short and 20% in the long spectral channel in ischemic retinal areas up to 3 days after retinal artery occlusion compared to the contralateral unaffected eyes. In the postacute disease stage there was no difference between the lifetimes of affected areas and unaffected fellow eyes.
CONCLUSIONS: Retinal artery occlusion leads to significantly longer fluorescence lifetimes of the retina in the acute phase and may serve as a useful indicator for acute ischemic retinal damage.

Entities:  

Mesh:

Year:  2015        PMID: 26024116     DOI: 10.1167/iovs.14-16203

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  13 in total

1.  Combination of confocal principle and aperture stop separation improves suppression of crystalline lens fluorescence in an eye model.

Authors:  Matthias Klemm; Johannes Blum; Dietmar Link; Martin Hammer; Jens Haueisen; Dietrich Schweitzer
Journal:  Biomed Opt Express       Date:  2016-08-01       Impact factor: 3.732

2.  Simplified approach to least-square fitting of fluorescence lifetime ophthalmoscopy (FLIO) data by fixating lifetimes.

Authors:  Rowena Schultz; Franziska Schuster; Thomas Lehmann; Johanna Schmidt; Regine Augsten; Martin Hammer
Journal:  Biomed Opt Express       Date:  2019-11-01       Impact factor: 3.732

3.  Fluorescence Lifetime Imaging Ophthalmoscopy: A Novel Way to Assess Macular Telangiectasia Type 2.

Authors:  Lydia Sauer; Rebekah H Gensure; Martin Hammer; Paul S Bernstein
Journal:  Ophthalmol Retina       Date:  2017-12-08

4.  FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY (FLIO) PATTERNS IN CLINICALLY UNAFFECTED CHILDREN OF MACULAR TELANGIECTASIA TYPE 2 (MACTEL) PATIENTS.

Authors:  Lydia Sauer; Alexandra S Vitale; Karl M Andersen; Barbara Hart; Paul S Bernstein
Journal:  Retina       Date:  2020-04       Impact factor: 3.975

5.  Homocysteine in retinal artery occlusive disease: A meta-analysis of cohort studies.

Authors:  Xuetao Huang; Yezhen Yang; Yiqin Duan; Yi-Qun Kuang; Ding Lin
Journal:  Sci Rep       Date:  2017-11-16       Impact factor: 4.379

6.  Characterization of Retinitis Pigmentosa Using Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO).

Authors:  Karl M Andersen; Lydia Sauer; Rebekah H Gensure; Martin Hammer; Paul S Bernstein
Journal:  Transl Vis Sci Technol       Date:  2018-06-22       Impact factor: 3.283

7.  FUNDUS AUTOFLUORESCENCE LIFETIMES AND CENTRAL SEROUS CHORIORETINOPATHY.

Authors:  Chantal Dysli; Lieselotte Berger; Sebastian Wolf; Martin S Zinkernagel
Journal:  Retina       Date:  2017-11       Impact factor: 4.256

8.  Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) of Macular Pigment.

Authors:  Lydia Sauer; Karl M Andersen; Binxing Li; Rebekah H Gensure; Martin Hammer; Paul S Bernstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-06-01       Impact factor: 4.799

9.  Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) in Eyes With Pigment Epithelial Detachments Due to Age-Related Macular Degeneration.

Authors:  Lydia Sauer; Christopher B Komanski; Alexandra S Vitale; Eric D Hansen; Paul S Bernstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-07-01       Impact factor: 4.799

10.  Moxifloxacin: Clinically compatible contrast agent for multiphoton imaging.

Authors:  Taejun Wang; Won Hyuk Jang; Seunghun Lee; Calvin J Yoon; Jun Ho Lee; Bumju Kim; Sekyu Hwang; Chun-Pyo Hong; Yeoreum Yoon; Gilgu Lee; Viet-Hoan Le; Seoyeon Bok; G-One Ahn; Jaewook Lee; Yong Song Gho; Euiheon Chung; Sungjee Kim; Myoung Ho Jang; Seung-Jae Myung; Myoung Joon Kim; Peter T C So; Ki Hean Kim
Journal:  Sci Rep       Date:  2016-06-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.